-
Will FDA Restrict Use Of Ketek And Put Increased “Black Box” Warning On Sanofi-Aventis Antibiotic?
FDA Advisory Panel: Ketek Side Effects Risks Outweigh Benefits For Bronchitis And Sinusitis; Urges Patient Medication Guide When Used For Pneumonia In mid-December 2006, after two days of hearings, an FDA advisory panel recommended…
-
New Birth Control Patch Warnings In Canada About Being Overweight, Sauna Or Whirlpool Heat
No Similar Changes To Ortho Evra Label In U.S. As Of Early December 2006 On November 23, 2006 Health Canada released a drug safety alert — which consisted of a so-called "Dear Doctor" letter…
-
David Graham’s NEJM Letter Concerning Sanofi-Aventis Antibiotic Ketek
Suggests That Reports Of Acute Liver Failure Support A Ketek Recall A November 22, 2006 Reuters article by Susan Heavey reports on the latest development as regards the continuing controversy surrounding Ketek (telithromycin), an…
-
Amount Of Epogen And Procrit Given To Patient Tripled Since Early ’90s
Higher Levels Of Popular Anemia Drugs May Increase Risk Of Heart Problems And Death The most recent discussion about safety issues surrounding the anemia drug epoetin — sold by Amgen as Epogen, sold by…
